• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Astec LifeSciences Limited — Important, 31-07-2026: Updates

    31-07-2026 | 10:07 pm

    Astec LifeSciences achieved strong FY26 revenue of ₹453.22 Cr, significantly cutting losses to ₹(80.88) Cr. A ₹249.35 Cr rights issue was completed, and credit ratings remained robust (ICRA AA- long-term, A1+ short-term). Strategic focus on CDMO and efficiency continues.

    No comments yet. Be the first to comment!

    All announcements from Astec LifeSciences Limited